Equities are a key component of every investor’s portfolio, making it important to learn the fundamentals and technicals required to invest successfully and with confidence. Discover how top professional investors separate fact from fiction to maximize their profit opportunities. From explosive IPOs to solid value plays, our experts can help you formulate the right action plan for your portfolio no matter where the markets are headed.

Articles on Stocks

As one of the world's largest biopharmaceutical companies, we think Pfizer (PFE) is well-positioned to outperform its peers; the stock carries our highest recommendation of 5-STARS, or Strong Buy, asserts analyst Sel Hardy in CFRA Research's flagship newsletter, The Outlook.
Amazon (AMZN) is a growth monster that keeps getting bigger, observes Tony Sagami, growth stock specialist and editor of Weiss Ultimate Portfolio.
Yes, stocks are down for 6 of the last 7 sessions, and the last 4 sessions have been closed further below 4,500, says Steve Reitmeister, editor of Reitmeister Total Return.
Weakness on Wednesday sent the S&P 500 (SPX) back very near critical support, says Jon Markman, editor of Pivotal Point.
W.P. Carey (WPC) is such a steady hand that we rarely pay much attention to it. All the company does is pay us a generous dividend (5.3%) and raise its payout every quarter. And all its stock price ever seems to do is grind higher, observes Brett Owens, chief investment strategist at Contrarian Income Report.
Almost any company that can establish a niche — even a relatively small niche — in an expected global infrastructure transformation will be immensely profitable, suggests Stephen Leeb, global resources sector specialist and editor of Investing Daily's The Complete Investor.
More than 45 years ago, Gentex (GNTX) opened its doors as a maker of high-quality fire protection products, notes Ingrid Hendershot, value-focused money manager and editor of Hendershot Investments.
The shares of communications and networking concern Juniper Networks, Inc (JNPR) looks like they reached their peak late last month, coming in at a nearly three-year high of $29.77 on Aug. 25, notes Lillian Currens, deputy editor of Bernie Schaeffer's advisory service, Schaeffer's Investment Research.
Earnings season ended with over 90% of reporting companies beating estimates. The strong market seemingly ignored fear of inflation or that the global Delta variant spread might stall the economic recovery, observes income expert Harry Domash, editor of Dividend Detective.
September is here. And that's usually a red month. But October through December are notoriously bullish for stocks, explains Lucas Downey of

Experts on Stocks

Virtual Expos

Virtual Learning

Gold prices dropped in the first half of 2021 but concerns about inflation and capital preservation may be part of a collection of macro factors that could drive higher prices for the rest of the year. For stock investors not accustomed to including gold in their portfolio composition, there may be some opportunities to consider in gold miners and royalty stocks. In this session, Doug Gerlach will discuss some of his favorite gold miners from the perspective of fundamental, long-term focused investors, taken from his market-beating <em>SmallCap Informer</em> newsletter.
Is your portfolio strategy accidentally on autopilot? Has greed been driving your behavior? What are you doing with the overvalued stocks in your portfolio? While it may be impossible to remove human nature and emotion completely from the investment decision-making process, it is possible to understand and control many of the invisible forces that influence how you invest. Learn to recognize how your fears and misperceptions can lead you down the wrong path, and how following many of Wall Street's maxims cause you to make "dumb" mistakes.
Zhittya Genesis Medicine, Inc., is developing novel pharmaceuticals that have the potential to treat and reverse diseases that account for more than 50% of all adult deaths, worldwide. In FDA-authorized clinical trials these drugs have shown remarkable success in reversing severe coronary artery disease and healing chronic diabetic foot ulcers. New clinical trials are planned in the coming year to treat patients with Parkinson's disease, ALS (Lou Gehrig's disease), multiple sclerosis, chronic stroke, and Alzheimer's disease. A very attractive Pre-IPO investment is now being offered to suitable investors to help fund the upcoming IPO, which has a firm commitment from a highly regarded securities firm and will take place in 5-6 months.
Stocks go up because there are more buyers than sellers. We need to focus our attention on when buyers come into the marketplace. That's the secret, only buyers drive prices higher. The good news is that this can actually be measured. Is it all about the US stock market now? Cycles, monetary policy, intermarket forecast, and insider accumulation can give us an answer.
The good news is the stock market is going to continue to post positive sales and earnings for the remainder of 2021. The bad news is that momentum has peaked, so the overall stock market is expected to lose breadth and power. The stocks that will continue to sustain positive sales and earnings momentum are expected to be market leaders. Louis Navellier will reveal his favorite A-rated growth stocks and, as a bonus, will also show you his favorite dividend growth stocks that are prospering form the collapse in bond yields.
<p>Cost reduction, stricter emissions regulations, government incentives, and the rollout of new and affordable models bring EVs within reach of the mass consumer. One analogy commonly used to describe such an inflection point is "hockey stick growth," where the distant awareness of a trend suddenly crystalizes into mainstream acceptance as the phenomenon takes off. This year, EVs are moving out of the future and into the driveways of the masses.</p><p>In this presentation, Anthony Sassine of KraneShares will cover:</p><ul><li>Why 2021 may finally be the tipping point for global EV adoption.</li><li>Components of the electric vehicle ecosystem, including car manufacturers, battery makers, raw materials, vehicle connectivity suppliers, alternative renewable energy sources including hydrogen, and more.</li><li>The global landscape: key EV manufacturers and components suppliers that are commanding substantial global market share that you may have never heard about.</li></ul>
Harry Boxer, founder of, shares insights into identify breakout trading opportunities for intraday as well as swing trades. In this presentation, he will cover how to use intraday technicals and patterns to uncover trading candidates on intraday and daily charts. He will discuss using price-volume surges as the key to identifying the most lucrative trades, and how to play opening gaps and early session patterns. Learn from this 50-year veteran trader and technical analyst, and author of the highly acclaimed <em>Profitable Day & Swing Trading</em> (Wiley), noted by <em>Stock Trader's Almanac</em> as the "2015 Best Investment Book of the Year."
Join and discover the weak track record of investors vs. the market and why they fail over 85% of the time. Steve Reitmeister will cover how you can solve this problem with his formula for picking better stocks.
Past is prologue: There are undeniable similarities between 1920-1921 and today. Brian Hicks sees a generational bull market for the rest of the decade as the American and global economies reopen from a very low base. Sectors and industries that will lead the charge are transportation, technology, medical technology, and energy. Mr. Hicks will reveal the five stocks he's buying now, and you should too.
Biotech Covid-19 vaccine development has demonstrated the power of biotech to change the world and make handsome returns for investors. With the Delta variant wrecking devastation worldwide, join this presentation to discover what's next. Can an oral vaccine be the difference maker to finally tame Covid-19?



While the mechanisms and machinations of the markets have changed a lot since Benjamin Graham first devised a practical method for analyzing stocks, or even since Peter Lynch racked up big wins picking equities for Fidelity's Magellan Fund, one thing remains true: companies that deliver constant profits for shareholders will see their share prices increase.

Lofty current valuations show that the easy money has already been made, and those looking to profit should be more selective going forward. So which sectors will lead the market over the months ahead? What’s the best way to limit risk in the current environment? You will find the answers to these questions and more from the top industry professionals on these pages, unlike watching the stock market news on TV. Going beyond the stock market news today, many investors are searching for investments that they can depend on. Of course, there's no such thing as a sure bet, but the top experts featured here will share the picks they think are the next best things and the sectors that are bound to thrive in the days and months ahead.

The current market environment is particularly well-suited for stock pickers and stock-trading experts—especially the experts featured here whose careers are devoted to uncovering the best opportunities available in even the most rapidly changing environment. Get easy access to the nation’s leading stock experts who regularly share their takes on where market trends are headed, where to find bargains, and how to stay ahead of the curve.

Watch videos and read articles by these experts and discover their outlooks on what’s ahead for stocks, but more importantly, identify the most compelling sectors and industry groups, as well as the specific buying opportunities for optimal growth or income. These pages are chock-full of valuable insights from our experts' varying perspectives and expertise.